Studies from our laboratory [10,11] as well as others [12] have identified nitric oxide donors as anticancer drug sensitizers which are capable of reversing resistance mediated by ABC transporters in human MDR tumor cells. The gene discussed is ABCG2; the disease is neoplasm.